These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures. Fisher AA, Southcott EK, Srikusalanukul W, Davis MW, Hickman PE, Potter JM, Smith PN. Ann Clin Lab Sci; 2007; 37(3):222-32. PubMed ID: 17709685 [Abstract] [Full Text] [Related]
5. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index. Beberashvili I, Sinuani I, Azar A, Yasur H, Feldman L, Efrati S, Averbukh Z, Weissgarten J. J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974 [Abstract] [Full Text] [Related]
7. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index. Lomonte C, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Basile C. J Nephrol; 2006 May; 19(1):70-6. PubMed ID: 16523429 [Abstract] [Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
10. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y. Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265 [Abstract] [Full Text] [Related]
12. Race and sex: predictors of the severity of hyperparathyroidism in peritoneal dialysis patients. Fan SL, Chan A, Raftery MJ, Yaqoob MM. Nephrology (Carlton); 2006 Feb 22; 11(1):15-20. PubMed ID: 16509926 [Abstract] [Full Text] [Related]
14. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy. Kato Y, Yamaguchi S, Yachiku S, Fujisawa M, Kawakami N. Hinyokika Kiyo; 2004 Nov 22; 50(11):755-62. PubMed ID: 15628534 [Abstract] [Full Text] [Related]
15. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study. Panuccio V, Cutrupi S, Pizzini P, Mallamaci F, Tripepi G, Zoccali C. Am J Kidney Dis; 2007 Dec 22; 50(6):1001-8. PubMed ID: 18037100 [Abstract] [Full Text] [Related]
17. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY. Clin Chim Acta; 2008 Jan 22; 387(1-2):31-5. PubMed ID: 17884030 [Abstract] [Full Text] [Related]
19. Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients. Shidara K, Inaba M, Okuno S, Imanishi Y, Yamakawa T, Ishimura E, Kumeda Y, Nishizawa Y. Biomed Pharmacother; 2007 Jan 22; 61(2-3):142-7. PubMed ID: 17270383 [Abstract] [Full Text] [Related]
20. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL. Am J Kidney Dis; 2009 Apr 22; 53(4 Suppl 4):S3-10. PubMed ID: 19285609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]